🔗 Share this article

A shadow economy for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Investigational Treatment Acquiring Traction Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Followers are urged to message these accounts privately for supplier links, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Separately, a flourishing market exists on Telegram, where communities with numerous of participants share “before and after” images, injection guides and assertions of next-day UK delivery. Sellers promote the substance there before redirecting customers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Experts Express Worries

Nevertheless, physicians and pharmacists have warned that the sale of what is still an unapproved drug in the UK is a cause for concern and could lead to users injecting substances of unknown origin.

Some professionals stated the demand for retatrutide could be linked to the increasing price of licensed weight loss products such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the British medical regulations.

Several influencers attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach medicines, advertising, and customer regulations, potentially leading to penalties, prosecution or prison.

Platform Reaction and Material Removal

Based on the social media company, the platform has taken down problematic content and prohibited related hashtags and query recommendations. The company stated it was dedicated to maintaining the service safe and allocating resources in enhancing enforcement strategies.

Digital Trading Activities

Investigations also discovered groups with up to 9,000 participants selling retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up channels with thousands of users, filled with images of weight loss, glowing reviews and step-by-step instructions for preparing or injecting at residence.

Within moments of entering one group, a seller posted contact information, where the majority of transactions take place. The seller provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about body mass, medical conditions or past usage.

Product Information and Pricing

Within these communities, posts display black plastic parcels with Royal Mail labels, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at residence with sterile water, or pre-filled injectors typically sold at 160 pounds for 20mg. When questioned how much time a pen should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Service Moderation and Security Actions

A representative for Telegram stated it regularly moderated dangerous material on its platform including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering substances they can’t verify. Although the research behind this drug is sound, these online products may not contain what they claim,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in interest to recent price rises for approved weight-loss medications such as Mounjaro. “With prices rising, patients are using online platforms. But fake injections are highly risky. You cannot know what’s contained or whether the environment they were made in was clean,” she said.

Her team has previously seen patients harmed by personal administration from unverified sources. “We recognize the disappointment, but buying from messaging apps or communication platforms is gambling with your well-being,” stated the doctor. “These materials could be impure or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company experimental substance not yet authorized … may expose users to possibly serious health risks”.